The mechanism by which UBAP2L variants cause developmental delay, speech delay, mild to severe intellectual disability (ID), seizures, hypotonia, behavioural abnormalities, hypotonia, skeletal and facial abnormalities, and other clinical symptoms remains unclear. This evidence concerns the gene UBAP2L and Delayed speech and language development.